Literature DB >> 2478413

The development of hepatocellular carcinoma from liver cirrhosis during a follow-up study.

H A Sulaiman1.   

Abstract

A prospective study was carried out in 126 cases with liver cirrhosis attending the outpatient clinic of Hepatology of the Department of Internal Medicine, Dr. Cipto Mangunkusmo Hospital Jakarta, between August 1, 1982 and Dec. 31, 1985. The patients consisted of 82 men and 44 women and there were 45 HBsAg positive cases (36.7%). HBeAg was positive in 35.6% (16/45) and 40.0% were anti-HBe positive while both markers were negative in 24.4%. During the follow-up study 27 cases died. The cause of death was due to variceal bleeding in 9 cases (33.3%) and hepatic failure in 9 cases (33.3%). In 6 cases (22.2%) hepatocellular carcinoma (HCC) was the cause of death. Nine cases out of 94 traceable cases (13.7%) were developed HCC. They consisted of 4 cases out of 29 cases (13.8%) with HBsAg positive and 5 cases out of 65 cases (7.7%). But no significant difference was observed between both groups. The length of observation period from the first time of diagnosis until development of HCC was from 1 to 6 years with an average of 2.9 years.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2478413     DOI: 10.1007/bf02773887

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  12 in total

1.  [Primary cancer of the liver; critical study of 240 cases].

Authors:  M PAYET; R CAMAIN; P PENE
Journal:  Rev Int Hepatol       Date:  1956

2.  Chronic liver disease and primary liver-cell cancer with hepatitis-associated (Australia) antigen in serum.

Authors:  S Sherlock; R A Fox; S P Niazi; P J Scheuer
Journal:  Lancet       Date:  1970-06-13       Impact factor: 79.321

3.  Hepatitis-associated antigen in chronic liver disease.

Authors:  S J Hadziyannis; G E Merikas; A P Afroudakis
Journal:  Lancet       Date:  1970-07-11       Impact factor: 79.321

4.  Hepatitis B virus and primary hepatocellular carcinoma.

Authors:  J L Gerin
Journal:  Gastroenterology       Date:  1983-04       Impact factor: 22.682

5.  HBeAg/anti-HBe system and development of primary hepatocellular carcinoma in patients with HBsAg-positive liver cirrhosis.

Authors:  A Musca; C Cordova; V Barnaba; M S Bonavita; M Levrero; C Zaccari; F Balsano
Journal:  Hepatogastroenterology       Date:  1983-02

Review 6.  Hepatocellular carcinoma and type B hepatitis.

Authors:  S J Hadziyannis
Journal:  Clin Gastroenterol       Date:  1980-01

7.  Detection of hepatocellular carcinoma during a clinical follow-up of chronic liver disease: observations in 31 patients.

Authors:  Y Kubo; K Okuda; H Musha; T Nakashima
Journal:  Gastroenterology       Date:  1978-03       Impact factor: 22.682

Review 8.  Relationship between hepatocellular carcinoma and cirrhosis.

Authors:  M C Kew; H Popper
Journal:  Semin Liver Dis       Date:  1984-05       Impact factor: 6.115

9.  Clinicopathological aspects of primary hepatocellular carcinoma occurring in patients with liver cirrhosis.

Authors:  K Iwamura
Journal:  Tokai J Exp Clin Med       Date:  1982-09

10.  Cirrhosis and primary liver carcinoma in Uganda Africans.

Authors:  P E STEINER; J N DAVIES
Journal:  Br J Cancer       Date:  1957-12       Impact factor: 7.640

View more
  3 in total

Review 1.  Insights Into the Coinfections of Human Immunodeficiency Virus-Hepatitis B Virus, Human Immunodeficiency Virus-Hepatitis C Virus, and Hepatitis B Virus-Hepatitis C Virus: Prevalence, Risk Factors, Pathogenesis, Diagnosis, and Treatment.

Authors:  Sagarika Shahriar; Yusha Araf; Rasel Ahmad; Pravakar Kattel; Ganga Sagar Sah; Tanjim Ishraq Rahaman; Rahila Zannat Sadiea; Shahnaj Sultana; Md Sayeedul Islam; Chunfu Zheng; Md Golzar Hossain
Journal:  Front Microbiol       Date:  2022-02-03       Impact factor: 5.640

Review 2.  Large variations in risk of hepatocellular carcinoma and mortality in treatment naïve hepatitis B patients: systematic review with meta-analyses.

Authors:  Maja Thiele; Lise Lotte Gluud; Annette Dam Fialla; Emilie Kirstine Dahl; Aleksander Krag
Journal:  PLoS One       Date:  2014-09-16       Impact factor: 3.240

Review 3.  HBV-HCV Coinfection: Viral Interactions, Management, and Viral Reactivation.

Authors:  Marianna G Mavilia; George Y Wu
Journal:  J Clin Transl Hepatol       Date:  2018-07-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.